Federal prosecutors charged two digital health company executives with carrying out a 100-million-dollar fraud scheme, distributing more than 40 million pills of Adderall and other prescription stimulants whether or not patients qualified. NBC News’ Maggie Vespa reports. NBC News Health
Federal prosecutors charged two digital health company executives with carrying out a 100-million-dollar fraud scheme, distributing more than 40 million pills of Adderall and other prescription stimulants whether or not patients qualified. NBC News’ Maggie Vespa reports.
